Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetics in Primary Headache Disorders.
Belyaeva II, Subbotina AG, Eremenko II, Tarasov VV, Chubarev VN, Schiöth HB, Mwinyi J. Belyaeva II, et al. Among authors: chubarev vn. Front Pharmacol. 2022 Feb 10;12:820214. doi: 10.3389/fphar.2021.820214. eCollection 2021. Front Pharmacol. 2022. PMID: 35222013 Free PMC article. Review.
Can Molecular Biology Propose Reliable Biomarkers for Diagnosing Major Depression?
Ivanets NN, Svistunov AA, Chubarev VN, Kinkulkina MA, Tikhonova YG, Syzrantsev NS, Sologova SS, Ignatyeva NV, Mutig K, Tarasov VV. Ivanets NN, et al. Among authors: chubarev vn. Curr Pharm Des. 2021;27(2):305-318. doi: 10.2174/1381612826666201124110437. Curr Pharm Des. 2021. PMID: 33234092 Review.
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA, Furuya H, Ng ML, Friedemann M, Menschikowski M, Tarasov VV, Chubarev VN, Klochkov SG, Neganova ME, Mangoni AA, Aliev G, Bishayee A. Sukocheva OA, et al. Among authors: chubarev vn. Pharmacol Ther. 2020 Mar;207:107464. doi: 10.1016/j.pharmthera.2019.107464. Epub 2019 Dec 18. Pharmacol Ther. 2020. PMID: 31863815 Review.
Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia.
Mishchenko DV, Neganova ME, Klimanova EN, Sashenkova TE, Klochkov SG, Shevtsova EF, Vystorop IV, Tarasov VV, Chubarev VN, Samsonova AN, Ashraf GM, Barreto G, Yarla NS, Aliev G. Mishchenko DV, et al. Among authors: chubarev vn. Curr Cancer Drug Targets. 2018;18(4):365-371. doi: 10.2174/1568009617666170623104030. Curr Cancer Drug Targets. 2018. PMID: 28669342
54 results